Skip to main content

Closed

ENTA: Enanta Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-87.2%

ROIC-19.9%

Financially safe

Stretched

Debt / equity1.60×

Interest coverage-5.8×

Current ratio3.84×

Enanta Pharmaceuticals, Inc.

ENTANASDAQ Global Select·USD·Closed

Enanta Pharmaceuticals, Inc.

ENTANASDAQ·USD·Closed

$12.60

−3.08%

$12.60

−$0.40 (3.08%)

52W Range

57thpctl

Volume

0.63×avg

Mkt Cap

366.39MUSD

P/E

-4.6TTM

Div Yield

–ann

52W Range

57thpctl

Volume

0.63×avg

Market Cap

366.39MUSD

P/E Ratio

-4.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings